Relationship of Metabolic Syndrome With Pulse Pressure in Patients With Essential Hypertension

American Journal of Hypertension

Volumn 20, Issue 2, 2007, Pages 197-203

  Mulè, Giuseppe ^a   Nardi, Emilio ^a   Cottone, Santina ^a   Cusimano, Paola ^a   Incalcaterra, Francesca ^a   Palermo, Alessandro ^a   Giandalia, Maria Ester ^a   Mezzatesta, Giovanni ^a   Andronico, Giuseppe ^a   Cerasola, Giovanni ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

arterial stiffness; Essential hypertension; metabolic syndrome; pulse pressure

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTERY COMPLIANCE; ARTERY STIFFNESS; ARTICLE; BLOOD CHEMISTRY; BLOOD PRESSURE MONITORING; BLOOD VESSEL PARAMETERS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; GENDER; HEART STROKE VOLUME; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PULSE PRESSURE; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ARTERIES; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PULSATILE FLOW; PULSE; RISK FACTORS;

EID: 33846415582     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2006.07.016     Document Type: Article

References (29)

1. Beevers D.G. Epidemiological, pathophysiological and clinical significance of systolic, diastolic and pulse pressure. J Hum Hypertens 18 (2004) 531-533
2. Dart A.M., and Kingwell B.A. Pulse pressure-A review of mechanisms and clinical relevance. J Am Coll Cardiol 37 (2001) 975-984
3. Lewington S., Clarke R., Qizilbash N., Peto R., and Collins R. Prospective Studies Collaboration, Age specific relevance of usual blood pressure to vascular mortality; one million adults in 61 prospective studies. Lancet 360 (2002) 1903-1913
4. Franklin S.S. Pulse pressure as a risk factor. Clin Exp Hypertens 26 (2004) 645-652
5. Pickering T.G. Measurement of blood pressure in and out of the office. J Clin Hypertens (Greenwich) 7 (2005) 123-129
6. Ben-Dov I.Z., Perk G., Ben-Arie L., Mekler J., and Bursztyn M. Pulse pressure is more susceptible to the white coat effect than is systolic blood pressure: observations from real-life ambulatory blood pressure monitoring. Am J Hypertens 17 (2004) 535-539
7. Verdecchia P., Schillaci G., Borgioni C., Ciucci A., Pede S., and Porcellati C. Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension 32 (1998) 983-988
8. Staessen J.A., Thijs L., O'Brien E.T., Bulpitt C.J., de Leeuw P.W., Fagard R.H., Nachev C., Palatini P., Parati G., Tuomilehto J., Webster J., Safar M.E., and Syst-Eur Trial Investigators. Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertension. Am J Hypertens 15 (2002) 835-843
9. Mulè G., Nardi E., Cottone S., Cusimano P., Volpe V., Piazza G., Mongiovi R., Mezzatesta G., Andronico G., and Cerasola G. Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med 257 (2005) 503-513
10. Mulè G., and Cerasola G. The metabolic syndrome and its relationship to hypertensive target organ damage. J Clin Hypertens (Greenwich) 8 (2006) 195-201
11. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith Jr. S.C., Spertus J.A., and Costa F. Diagnosis and management of the metabolic syndrome. An American Heart Association/ National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 21 (2006) 1-6
12. Mulè G., Cottone S., Mongiovì R., Cusimano P., Mezzatesta G., Seddio G., Volpe V., Nardi E., Andronico G., Piazza G., and Cerasola G. Influence of metabolic syndrome on aortic stiffness in never treated hypertensive patients. Nutr Metab Cardiovasc Dis 16 (2006) 54-59
13. Schillaci G., Pirro M., Vaudo G., Mannarino M.R., Savarese G., Pucci G., Franklin S.S., and Mannarino E. Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension. Hypertension 45 (2005) 1078-1082
14. Scuteri A., Najjar S.S., Muller D.C., Andres R., Hougaku H., Metter E.J., and Lakatta E.G. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 43 (2004) 1388-1395
15. Ferreira I., Henry R.M., Twisk J.W., van Mechelen W., Kemper H.C., and Stehouwer C.D. The metabolic syndrome, cardiopulmonary fitness, and subcutaneous trunk fat as independent determinants of arterial stiffness: the Amsterdam Growth and Health Longitudinal Study. Arch Intern Med 165 (2005) 875-882
16. Safar M.E., Thomas F., Blacher J., Nzietchueng R., Bureau J.M., Pannier B., and Benetos A. Metabolic syndrome and age-related progression of aortic stiffness. J Am Coll Cardiol 47 (2006) 72-75
17. Li S., Chen W., Srinivasan S.R., and Berenson G.S. Influence of metabolic syndrome on arterial stiffness and its age-related change in young adults: the Bogalusa Heart Study. Atherosclerosis 180 (2005) 349-354
18. Asmar R., Vol S., Brisac A.M., Tichet J., and Topouchian J. Reference values for clinic pulse pressure in a nonselected population. Am J Hypertens 14 (2001) 415-418
19. Verdecchia P., Reboldi G.P., Angeli F., Schillaci G., Schwartz J.E., Pickering T.G., Imai Y., Ohkubo T., and Kario K. Short-and long-term incidence of stroke in white-coat hypertension. Hypertension 45 (2005) 203-208
20. Sahn D.J., DeMaria A., Kisslo J., and Weiman A. The Committee on M-mode standardization of the American Society of Echocardiography. Circulation 58 (1978) 1072-1073
21. Teicholz L.E., Kreulen T., Herman M.V., and Gorlin R. Problems in echocardiografic volume determinations: echocardiografic-angiografic correlations in the presence or absence of asynergy. Am J Cardiol 37 (1976) 7-11
22. Onat A., Hergenc G., Keles I., Dogan Y., Turkmen S., and Sansoy V. Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome. Metabolism 54 (2005) 800-808
23. Hansel B., Giral P., Nobecourt E., Chantepie S., Bruckert E., Chapman M.J., and Kontush A. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 89 (2004) 4963-4971
24. Soldatos G., Cooper M.E., and Jandeleit-Dahm K.A. Advanced-glycation end products in insulin-resistant states. Curr Hypertens Rep 7 (2005) 96-102
25. Steinberg H.O., Chaker H., Leaming R., Johnson A., Brechtel G., and Baron A.D. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97 (1996) 2601-2610
26. Singhal A., Farooqi I.S., Cole T.J., O'Rahilly S., Fewtrell M., Kattenhorn M., Lucas A., and Deanfield J. Influence of leptin on arterial distensibility. A novel link between obesity and cardiovascular disease?. Circulation 106 (2002) 1919-1924
27. Matsuzawa Y., Funahashi T., Kihara S., and Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24 (2004) 29-33
28. Mahmud A., and Feely J. Adiponectin and arterial stiffness. Am J Hypertens 18 (2005) 1543-1548
29. Mulè G., Nardi E., Andronico G., Cottone S., Federico M.R., Piazza G., Volpe V., Ferrara D., and Cerasola G. Pulsatile and steady 24-h blood pressure components as determinants of left ventricular mass in young and middle-aged essential hypertensives. J Hum Hypertens 17 (2003) 231-238